When are you incorporating nivolumab in the treatment of relapsed HL?

When are you incorporating nivolumab in the treatment of HL?

• Relapsed/refractory disease after 3 prior lines of therapy including autologous transplant
• 3rd line therapy if prior brentuximab vedotin and autologous transplant
• In transplant-ineligible patients based on comorbidity or failure of first salvage chemotherapy
• Other